Clinical Trial

Telecommunication Technology-based Online Survey

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to identify and assess new health-associated risk factors, including clinical-pharmacological risk factors. The cohort is built using telecommunication approaches. The associations between clinical-pharmacological, social, demographic, behavioral, and environmental characteristics will be assessed. The continuous depersonalized online survey is performed using the original informational resources in the form of specially designed web-site aimed at identification and assessment of population-based pharmacotherapy patterns including characteristics of self-medication, biologically active food supplement intake, polypharmacy, and adverse drug-drug interactions in the people residing in the ecological conditions of various regions of the country. The invitations to participate in the online survey are sent via the SMS messages using the SMS-Target tool provided by OOO T2 Mobile Company. The survey is performed online at www.zdorov.tpu.ru and www.zdorov.expert both specifically designed for questionnaire publication and data accumulation.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-11-28; most recent amendment 2026-01-23.
Trial Details
NCT Number NCT06159699
Lead Sponsor Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions Risk Factors, Polypharmacy, Drug Interactions, Self Medication, COVID-19
Enrollment 2,000 participants
Start Date 2022-12-02
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-27